HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.

Abstract
Febrile ulcero-necrotic Mucha-Habermann disease (FUMHD) is a rare subtype of pityriasis lichenoides et varioliformis acuta (only 41 cases described to date), characterized by an acute onset of ulcero-necrotic papules accompanied by high fever and severe constitutional symptoms. We report a case of a 23-year-old man with a steroid-resistant FUMHD treated by intravenous immunoglobulins (IVIG) combined with methotrexate. Only one case of FUMHD treated by IVIG has been reported to date in literature. Also in our case, IVIG proved to be effective in inducing a dramatic improvement of ulceration and in arresting the appearance of new lesions. Moreover, in our experience we decided to perform a maintenance treatment with extracorporeal photochemotherapy (ECP), to the best of our knowledge not previously used in the treatment of pityriasis lichenoides et varioliformis acuta. ECP, which involves extracorporeal exposure of peripheral blood mononuclear cells to photo-activated 8-methoxypsoralen, induces an immunological reaction against auto-reactive T cell clones, without immune-depression and thus could potentially be useful particularly in FUMHD avoiding the risk of an infective reactivation.
AuthorsFederica Marenco, Paolo Fava, Maria Teresa Fierro, Pietro Quaglino, Maria Grazia Bernengo
JournalDermatologic therapy (Dermatol Ther) 2010 Jul-Aug Vol. 23 Issue 4 Pg. 419-22 ISSN: 1529-8019 [Electronic] United States
PMID20666830 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dermatologic Agents
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Methotrexate
Topics
  • Combined Modality Therapy
  • Dermatologic Agents (therapeutic use)
  • Fever (etiology)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Male
  • Methotrexate (therapeutic use)
  • Necrosis (pathology, therapy)
  • Photopheresis (methods)
  • Pityriasis Lichenoides (pathology, therapy)
  • Skin Ulcer (pathology, therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: